Cite
Efficacy and safety of intra-operative thromboprophylaxis with low-molecular-weight-heparin or heparin in patients undergoing surgical resection of colorectal cancer: A post-hoc analysis of the PERIOP-01 trial.
MLA
Wang, Tzu-Fei, et al. “Efficacy and Safety of Intra-Operative Thromboprophylaxis with Low-Molecular-Weight-Heparin or Heparin in Patients Undergoing Surgical Resection of Colorectal Cancer: A Post-Hoc Analysis of the PERIOP-01 Trial.” Thrombosis Research, vol. 242, Oct. 2024, p. 109123. EBSCOhost, https://doi.org/10.1016/j.thromres.2024.109123.
APA
Wang, T.-F., Mallick, R., Noureldin, A., Pecarskie, A., Carrier, M., & Auer, R. (2024). Efficacy and safety of intra-operative thromboprophylaxis with low-molecular-weight-heparin or heparin in patients undergoing surgical resection of colorectal cancer: A post-hoc analysis of the PERIOP-01 trial. Thrombosis Research, 242, 109123. https://doi.org/10.1016/j.thromres.2024.109123
Chicago
Wang, Tzu-Fei, Ranjeeta Mallick, Abdelrahman Noureldin, Amanda Pecarskie, Marc Carrier, and Rebecca Auer. 2024. “Efficacy and Safety of Intra-Operative Thromboprophylaxis with Low-Molecular-Weight-Heparin or Heparin in Patients Undergoing Surgical Resection of Colorectal Cancer: A Post-Hoc Analysis of the PERIOP-01 Trial.” Thrombosis Research 242 (October): 109123. doi:10.1016/j.thromres.2024.109123.